Search results
Results from the WOW.Com Content Network
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
Where to invest $1,000 right now? ... While the technology will be transformative, ... the average S&P 500 company has a P/S ratio around 3. Prospective investors should avoid Rigetti, and current ...
CRISPR Therapeutics is applying this technology platform to research, develop and commercialize medicines for various diseases including sickle cell disease, beta thalassemia, various cancers, type 1 diabetes, and cardiovascular diseases. [7] The CEO is Samarth Kulkarni, PhD, who joined the company in 2015 as chief business officer.
In September the company announced it would acquire Dezima Pharma for more than $1.55 billion. [66] [67] The same day the company announced a collaboration with Xencor on 6 early stage immuno-oncology and inflammation programmes. As part of the deal Amgen will pay $45 million upfront, with the deal being worth up to another $1.7 billion.
Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise ...
For premium support please call: 800-290-4726 more ways to reach us
Investing in innovative technology can be an exhilarating journey, providing you with the opportunity to tap into advancements that could shape our future. To navigate this exciting landscape ...